Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.36 |
| ▸ | CA2 | P00918 | 6/20 | 0.36 |
| ▸ | MMP1 | P03956 | 6/20 | 0.36 |
| ▸ | MMP2 | P08253 | 6/20 | 0.36 |
| ▸ | MMP9 | P14780 | 6/20 | 0.36 |
| ▸ | MMP8 | P22894 | 6/20 | 0.36 |
| ▸ | MMP13 | P45452 | 6/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3188419 | 0.79 | CA2 (0.43) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL5702180 | 0.78 | CA1 (0.42) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL11787529 | 0.78 | CA2 (0.45) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL5399542 | 0.78 | CA2 (0.45) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL3646279 | 0.77 | CA2 (0.44) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL9070226 | 0.77 | CA2 (0.44) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL7621877 | 0.71 | TSHR (0.45) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL740188 | 0.70 | CA2 (0.47) | CA1CA2MMP1MMP2MMP9 | |
| SCHEMBL10151019 | 0.70 | ALDH1A1 (0.41) | — | |
| SCHEMBL7623737 | 0.69 | CA1 (0.48) | CA1CA2MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1246856-A1 | FLUOROCHEMICAL SULFONAMIDE SURFACTANTS | 3M Innovative Properties Company (US) | 2002-10-09 | — | — | EP | disclosed |
| WO-2001030873-A1 | FLUOROCHEMICAL SULFONAMIDE SURFACTANTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-05-03 | — | — | WO | disclosed |